Targeted Approaches Improve Survival in CLL Compared with Chemo-Immunotherapy
Treatment strategies for chronic lymphocytic leukemia (CLL)
have shifted away from chemo-immunotherapy-based approaches to more targeted
therapeutics. During a presentation at NAMCP 2020 Virtual...
Considerations for IBD Treatment and Barriers to Appropriate Care
Inflammatory bowel disease (IBD; including ulcerative
colitis and Crohn’s disease) is a chronic, heterogenous immune-mediated
inflammatory disorder, for which early, multidisciplinary interventions to
induce and...
Current and Pipeline Treatment Options for Psoriatic Arthritis
Psoriatic arthritis (PsA) occurs in 6% to 41% of patients
with psoriasis but goes frequently undiagnosed by dermatologists. However,
earlier treatment initiation is beneficial....
Management Strategies for Insomnia
Approximately 30% of the general population experiences
insomnia symptoms, and 6% to 10% have symptoms associated with daytime
functional impairment. During a presentation at...
A Review of Treatment Options for Metastatic and Non-Metastatic Prostate Cancer
Prostate cancer is the second most common cancer in men,
with approximately 1.1 million new cases and 307,000 deaths reported in 2012,
making it...